129 related articles for article (PubMed ID: 9632707)
1. Reduction of the major swine xenoantigen, the alpha-galactosyl epitope by transfection of the alpha2,3-sialyltransferase gene.
Tanemura M; Miyagawa S; Koyota S; Koma M; Matsuda H; Tsuji S; Shirakura R; Taniguchi N
J Biol Chem; 1998 Jun; 273(26):16421-5. PubMed ID: 9632707
[TBL] [Abstract][Full Text] [Related]
2. Reduction of the major xenoantigen on glycosphingolipids of swine endothelial cells by various glycosyltransferases.
Koma M; Miyagawa S; Honke K; Ikeda Y; Koyota S; Miyoshi S; Matsuda H; Tsuji S; Shirakura R; Taniguchi N
Glycobiology; 2000 Jul; 10(7):745-51. PubMed ID: 10910978
[TBL] [Abstract][Full Text] [Related]
3. The possibility of reducing xenoantigen levels with a novel gal 3'-sulfotransferase (GP3ST).
Koma M; Miyagawa S; Honke K; Nakai R; Miyoshi S; Ohta M; Matsuda H; Shirakura R; Taniguchi N
J Biochem; 2002 Apr; 131(4):517-22. PubMed ID: 11926988
[TBL] [Abstract][Full Text] [Related]
4. Effects of Gal beta 1,4 GlcNAc alpha 2,6-D-Sialyl transferase on swine xenoantigen.
Koma M; Miyagawa S; Koyota S; Yoshitatsu M; Miyoshi S; Matsuda H; Tsuji S; Shirakura R; Taniguchi N
Transplant Proc; 2000 Nov; 32(7):2509-10. PubMed ID: 11120271
[No Abstract] [Full Text] [Related]
5. Expression of alpha-1,3-galactose and other type 2 oligosaccharide structures in a porcine endothelial cell line transfected with human alpha-1,2-fucosyltransferase cDNA.
Sepp A; Skacel P; Lindstedt R; Lechler RI
J Biol Chem; 1997 Sep; 272(37):23104-10. PubMed ID: 9287311
[TBL] [Abstract][Full Text] [Related]
6. Expression of human alpha-galactosidase and alpha1,2-fucosyltransferase genes modifies the cell surface Galalpha1,3Gal antigen and confers resistance to human serum-mediated cytolysis.
Jia Y; Ren H; Gao X; Ji S; Yang J; Liu Z; Li S; Zhang Y
Chin Med Sci J; 2004 Mar; 19(1):31-7. PubMed ID: 15104222
[TBL] [Abstract][Full Text] [Related]
7. Alpha 1,3-galactosyltransferase deficiency in pigs increases sialyltransferase activities that potentially raise non-gal xenoantigenicity.
Park JY; Park MR; Kwon DN; Kang MH; Oh M; Han JW; Cho SG; Park C; Kim DK; Song H; Oh JW; Kim JH
J Biomed Biotechnol; 2011; 2011():560850. PubMed ID: 22131812
[TBL] [Abstract][Full Text] [Related]
8. Effect of various glycosyltransferases on the swine xenoantigen.
Koma M; Miyagawa S; Honke K; Ikeda Y; Koyota S; Murase A; Tsuji S; Miyoshi S; Matsuda H; Shirakura R; Taniguchi N
Transplant Proc; 2000 Aug; 32(5):855. PubMed ID: 10936241
[No Abstract] [Full Text] [Related]
9. Significant downregulation of the major swine xenoantigen by N-acetylglucosaminyltransferase III gene transfection.
Tanemura M; Miyagawa S; Ihara Y; Matsuda H; Shirakura R; Taniguchi N
Biochem Biophys Res Commun; 1997 Jun; 235(2):359-64. PubMed ID: 9199197
[TBL] [Abstract][Full Text] [Related]
10. Elevation of alpha2-->6 sialyltransferase and alpha1-->2 fucosyltransferase activities in human choriocarcinoma.
Fukushima K; Hara-Kuge S; Seko A; Ikehara Y; Yamashita K
Cancer Res; 1998 Oct; 58(19):4301-6. PubMed ID: 9766657
[TBL] [Abstract][Full Text] [Related]
11. Genetic engineering of CHO cells producing human interferon-gamma by transfection of sialyltransferases.
Fukuta K; Yokomatsu T; Abe R; Asanagi M; Makino T
Glycoconj J; 2000 Dec; 17(12):895-904. PubMed ID: 11511814
[TBL] [Abstract][Full Text] [Related]
12. Cell surface n-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells.
Dimitroff CJ; Pera P; Dall'Olio F; Matta KL; Chandrasekaran EV; Lau JT; Bernacki RJ
Biochem Biophys Res Commun; 1999 Mar; 256(3):631-6. PubMed ID: 10080950
[TBL] [Abstract][Full Text] [Related]
13. Reduction of metastatic properties of BL6 melanoma cells expressing terminal fucose(alpha)1-2-galactose after alpha1,2-fucosyltransferase cDNA transfection.
Gorelik E; Xu F; Henion T; Anaraki F; Galili U
Cancer Res; 1997 Jan; 57(2):332-6. PubMed ID: 9000578
[TBL] [Abstract][Full Text] [Related]
14. Reduction of alpha-galactosyl xenoantigen by expression of endo-beta-galactosidase C in pig endothelial cells.
Ogawa H; Kobayashi T; Yokoyama I; Nagatani N; Mizuno M; Yoshida J; Kadomatsu K; Muramatsu H; Nakao A; Muramatsu T
Xenotransplantation; 2002 Jul; 9(4):290-6. PubMed ID: 12060465
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the specificity of sialyltransferases toward mucin core 2, globo, and related structures. identification of the sialylation sequence and the effects of sulfate, fucose, methyl, and fluoro substituents of the carbohydrate chain in the biosynthesis of selectin and siglec ligands, and novel sialylation by cloned alpha2,3(O)sialyltransferase.
Chandrasekaran EV; Xue J; Xia J; Chawda R; Piskorz C; Locke RD; Neelamegham S; Matta KL
Biochemistry; 2005 Nov; 44(47):15619-35. PubMed ID: 16300412
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of Galalpha1,3Gal epitope in polymeric and monomeric IgM secreted by mouse myeloma cells deficient in alpha2, 6-sialyltransferase.
Smilovich D; Malagolini N; Fagioli C; de Lalla C; Sitia R; Serafini-Cessi F
Glycobiology; 1998 Aug; 8(8):841-8. PubMed ID: 9637816
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.
Schneider F; Kemmner W; Haensch W; Franke G; Gretschel S; Karsten U; Schlag PM
Cancer Res; 2001 Jun; 61(11):4605-11. PubMed ID: 11389097
[TBL] [Abstract][Full Text] [Related]
18. An attempt to downregulate the Hanganutziu-Deicher antigen by overexpression of glycosyltransferases.
Murase A; Miyagawa S; Koma M; Ikeda Y; Honke K; Wakamiya N; Tuji S; Shirakura R; Taniguchi N
Transplant Proc; 2000 Nov; 32(7):2507-8. PubMed ID: 11120270
[No Abstract] [Full Text] [Related]
19. Molecular cloning of a novel alpha2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids.
Okajima T; Fukumoto S; Miyazaki H; Ishida H; Kiso M; Furukawa K; Urano T; Furukawa K
J Biol Chem; 1999 Apr; 274(17):11479-86. PubMed ID: 10206952
[TBL] [Abstract][Full Text] [Related]
20. Alpha2,6-sialylation of cell-surface N-glycans inhibits glioma formation in vivo.
Yamamoto H; Oviedo A; Sweeley C; Saito T; Moskal JR
Cancer Res; 2001 Sep; 61(18):6822-9. PubMed ID: 11559557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
